Literature DB >> 20392976

Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.

Bertrand Audoin1, Wafaa Zaaraoui, Françoise Reuter, Audrey Rico, Irina Malikova, Sylviane Confort-Gouny, Patrick J Cozzone, Jean Pelletier, Jean-Philippe Ranjeva.   

Abstract

BACKGROUND: The existence of grey matter (GM) atrophy right after the first clinical event suggestive of multiple sclerosis (MS) remains controversial. The aim of this study was therefore to establish whether regional GM atrophy is already present in the earliest stage of MS assessing regional GM atrophy in a large group of patients.
METHODS: Sixty-two patients with a clinically isolated syndrome (CIS) were examined on a 1.5 T MR imager within 6 months after their first clinical events. A group of 37 matched healthy control subjects were also included in the study. An optimised voxel-based morphometry (VBM) method customised for MS was applied on volumetric T(1)-weighted images. The functional status of patients was assessed using the Expanded Disability Status Scale (EDSS) and the Brief Repeatable Battery.
RESULTS: VBM analysis (p<0.005, familywise error corrected) on patients versus control subjects showed the presence of significant focal GM atrophy in patients involving the bilateral insula, the bilateral orbitofrontal cortices, the bilateral internal and inferior temporal regions, the posterior cingulate cortex, the bilateral thalami, the bilateral caudate nuclei, the bilateral lenticular nuclei and the bilateral cerebellum. EDSS was slightly correlated (rho=-0.37 p=0.0027) with the atrophy of the right cerebellum. No correlations have been evidenced between the cognitive status of patients and the regional GM atrophy.
CONCLUSION: The present study performed on a large group of CIS patients demonstrated that regional GM atrophy is present right after the first clinical event of multiple sclerosis and mainly affects the deep GM and the limbic system.

Entities:  

Mesh:

Year:  2010        PMID: 20392976     DOI: 10.1136/jnnp.2009.188748

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  64 in total

1.  Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Quantitative susceptibility mapping in multiple sclerosis.

Authors:  Christian Langkammer; Tian Liu; Michael Khalil; Christian Enzinger; Margit Jehna; Siegrid Fuchs; Franz Fazekas; Yi Wang; Stefan Ropele
Journal:  Radiology       Date:  2013-01-11       Impact factor: 11.105

3.  Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Authors:  Maxime Donadieu; Yann Le Fur; Angèle Lecocq; Andrew A Maudsley; Soraya Gherib; Elisabeth Soulier; Sylviane Confort-Gouny; Fanelly Pariollaud; Marie-Pierre Ranjeva; Jean Pelletier; Maxime Guye; Wafaa Zaaraoui; Bertrand Audoin; Jean-Philippe Ranjeva
Journal:  J Magn Reson Imaging       Date:  2016-01-12       Impact factor: 4.813

4.  Quantitative T2' imaging in patients with clinically isolated syndrome.

Authors:  L Y Reitz; M Inglese; J Fiehler; J Finsterbusch; B Holst; C Heesen; R Martin; S Schippling
Journal:  Acta Neurol Scand       Date:  2012-01-03       Impact factor: 3.209

5.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

Review 6.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

7.  Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI.

Authors:  Aline M Thomas; Jiadi Xu; Peter A Calabresi; Peter C M van Zijl; Jeff W M Bulte
Journal:  Neuroimage       Date:  2019-10-09       Impact factor: 6.556

Review 8.  The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Authors:  Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

Review 9.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

Review 10.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.